Skip to main content

Advertisement

Log in

Iliopelvic lymphoscintigraphy with99mTc-dextran in malignant lymphoma

  • Original article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

99mTc-Dextran (99mTc-D) was evaluated as an iliopelvic lymphoscintigraphic agent in 49 patients with malignant lymphoma and the results were compared with ultrasound (US), lymphangiography (LA) and CT where available. Scintigrams were obtained by a gamma camera at 2 h postinjection and evaluated by comparing opposite sides. In 29 of 49 patients, normal lymphoscintigrams of excellent quality, deliniating the iliopelvic and paraaortic lymph nodes bilaterally were obtained. In 20 patients lymphoscintigraphy (LS) was positive. US was performed in 46 patients, 20 had positive and 26 negative findings. There was one false positive and one false negative in LS compared to US. Ten patients had LA and 3 had CT. These results were in complete agreement with LS. There was also a positive correlation between the clinical stages and the results of LS. This study showed that99mTc-D is an excellent radiopharmaceutical for the visualization of the lymph system with high correlation with other imaging modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Alavi A, Staum MM, Shesol BF, Bloch PH (1978) Technetium-99m stannous phytate as an imaging agent for lymph nodes. J Nucl Med 19:422–426

    Google Scholar 

  • Aras T, Ercan MT, Kaya S (1986) Cervical lymphoscintigraphy with99mTc-dextran. Nucl Med 25:A75

    Google Scholar 

  • Arzoumanian A, Rosenthall L, Seto H (1977) Clinical comparison of Tc-99m labelled preformed phytate colloid and sulphur colloid. Concise communication. J Nucl Med 18:118–120

    Google Scholar 

  • Ege GN, Cummings BJ (1980) Interstitial radiocolloid iliopelvic lymphoscintigraphy: Technique, anatomy and clinical application. Int J Radiat Oncol Biol Phys 6:1483–1490

    Google Scholar 

  • Ercan MT, Ekici E, Aras T, Öztürk AY, Erbengi G, Akoguz K, Albayrak A, Inal E, Altinok M (1984) Lymphoscintigraphy using99mTc-dextran. I. A comparative study with99mTc-anti-mony sulphide colloid. Turk J Res Med Sci 2:268–272

    Google Scholar 

  • Ercan MT, Schneidereit M, Senekowitsch R, Kriegel H (1985a) Evaluation of99mTc-dextran as a lymphoscintigraphic agent in rabbits. Eur J Nucl Med 11: 80–84

    Google Scholar 

  • Ercan MT, Schneidereit M, Senekowitsch R, Kriegel H (1985b) Evaluation of99mTc-dextran for blood-pool-imaging. Turk J Res Med Sci 3:246–249

    Google Scholar 

  • Ercan MT, Aras T, Ekici E (1986) Evaluation of99mTc-dextran for iliopelvic lymphoscintigraphy in normal subjects. Nucl Med 25:A107

    Google Scholar 

  • Henze E, Schelbert HR, Collins JD, Najafi A, Bario JR, Bennett LR (1982) Lymphoscintigraphy with Tc-99m labelled dextran. J Nucl Med 23:923–929

    Google Scholar 

  • Juma N, Andrey T, Ege GN (1985) Comparison as a lymphoscintigraphic agent between99mTc dextran and99mTc antimony sulphide colloid. Br J Radiol 58:325–330

    Google Scholar 

  • Karayalçm B, Aras G, Erbay G, Ercan MT (1988) Parastemal lymphoscintigraphy using99mTc-dextran. Nucl Med Commun 9:657–662

    Google Scholar 

  • Kazem I, Antoniades J, Brady LW, Faust DS, Croll MN, Lightfoot D (1968) Clinical evaluation of lymph node scanning utilizing colloidal gold 198. Radiology 90:905–911

    Google Scholar 

  • Taaning E, Holten I, Specht L, Jorgensen J (1985) Comparison of99mTc lymphoscintigraphy and lymphangiography in patients with malignant lymphomas. Acta Radiol 26: 79–83

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naldöken, S., Ercan, M.T. & Bekdik, C.F. Iliopelvic lymphoscintigraphy with99mTc-dextran in malignant lymphoma. Eur J Nucl Med 16, 143–147 (1990). https://doi.org/10.1007/BF01146852

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01146852

Key words

Navigation